Xylem Inc. (NYSE:XYL) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

Shares of Xylem Inc. (NYSE:XYLGet Free Report) have been given an average recommendation of “Moderate Buy” by the thirteen analysts that are currently covering the firm, MarketBeat reports. Six investment analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 12 month price target among brokerages that have issued a report on the stock in the last year is $152.7692.

Several analysts recently commented on XYL shares. UBS Group increased their price objective on shares of Xylem from $132.00 to $133.00 and gave the company a “neutral” rating in a research report on Wednesday, April 29th. Oppenheimer decreased their target price on shares of Xylem from $160.00 to $158.00 and set an “outperform” rating for the company in a report on Wednesday, April 29th. JPMorgan Chase & Co. cut their price target on shares of Xylem from $170.00 to $160.00 and set an “overweight” rating on the stock in a report on Thursday, April 16th. Barclays reduced their price target on shares of Xylem from $156.00 to $154.00 and set an “overweight” rating for the company in a research report on Wednesday, April 29th. Finally, TD Cowen restated a “hold” rating on shares of Xylem in a report on Monday, February 23rd.

Get Our Latest Stock Analysis on XYL

Insiders Place Their Bets

In related news, CAO Geri-Michelle Mcshane sold 4,269 shares of the business’s stock in a transaction that occurred on Thursday, May 7th. The shares were sold at an average price of $117.46, for a total transaction of $501,436.74. Following the completion of the sale, the chief accounting officer directly owned 3,605 shares in the company, valued at approximately $423,443.30. The trade was a 54.22% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Jerome A. Peribere purchased 1,210 shares of the company’s stock in a transaction dated Monday, May 4th. The shares were acquired at an average price of $116.61 per share, for a total transaction of $141,098.10. Following the purchase, the director directly owned 27,209 shares in the company, valued at approximately $3,172,841.49. The trade was a 4.65% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. 0.32% of the stock is currently owned by insiders.

Institutional Trading of Xylem

Hedge funds and other institutional investors have recently bought and sold shares of the stock. J. Stern & Co. LLP lifted its stake in shares of Xylem by 12,326.6% during the 4th quarter. J. Stern & Co. LLP now owns 45,448,168 shares of the industrial products company’s stock valued at $6,189,132,000 after buying an additional 45,082,435 shares in the last quarter. Vanguard Group Inc. increased its stake in Xylem by 0.5% in the 4th quarter. Vanguard Group Inc. now owns 30,054,743 shares of the industrial products company’s stock worth $4,092,855,000 after buying an additional 152,507 shares in the last quarter. State Street Corp raised its holdings in Xylem by 2.6% during the fourth quarter. State Street Corp now owns 11,233,427 shares of the industrial products company’s stock valued at $1,529,768,000 after acquiring an additional 280,221 shares during the period. Geode Capital Management LLC lifted its position in shares of Xylem by 2.4% in the fourth quarter. Geode Capital Management LLC now owns 6,357,278 shares of the industrial products company’s stock valued at $862,364,000 after acquiring an additional 151,754 shares in the last quarter. Finally, Swedbank AB lifted its position in shares of Xylem by 0.3% in the first quarter. Swedbank AB now owns 5,526,725 shares of the industrial products company’s stock valued at $660,444,000 after acquiring an additional 18,759 shares in the last quarter. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Xylem Stock Performance

Shares of XYL opened at $110.03 on Friday. The company has a 50-day simple moving average of $116.99 and a two-hundred day simple moving average of $128.54. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.46 and a quick ratio of 1.10. The firm has a market capitalization of $26.15 billion, a PE ratio of 27.37, a price-to-earnings-growth ratio of 1.56 and a beta of 1.04. Xylem has a one year low of $105.29 and a one year high of $154.27.

Xylem (NYSE:XYLGet Free Report) last posted its quarterly earnings data on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.09 by $0.03. The business had revenue of $2.13 billion during the quarter, compared to the consensus estimate of $2.11 billion. Xylem had a return on equity of 11.26% and a net margin of 10.79%.The firm’s quarterly revenue was up 2.7% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.03 earnings per share. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. On average, analysts anticipate that Xylem will post 5.51 EPS for the current fiscal year.

Xylem Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, June 25th. Shareholders of record on Thursday, May 28th will be paid a dividend of $0.43 per share. The ex-dividend date is Thursday, May 28th. This represents a $1.72 annualized dividend and a yield of 1.6%. Xylem’s dividend payout ratio is currently 42.79%.

Xylem declared that its Board of Directors has authorized a share buyback plan on Wednesday, February 25th that authorizes the company to buyback $1.50 billion in outstanding shares. This buyback authorization authorizes the industrial products company to buy up to 4.8% of its stock through open market purchases. Stock buyback plans are usually an indication that the company’s leadership believes its shares are undervalued.

About Xylem

(Get Free Report)

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.

Further Reading

Analyst Recommendations for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.